Martin Wichmann

Frequency and prognostic impact of mutations in SRSF2, U2AF1, and ZRSR2 in patients with myelodysplastic syndromes

Felicitas Thol, Sofia Kade, Carola Schlarmann et al. · Blood · 2012 · 418 citations · Full text

Medicine, Genetics, Molecular Genetics +11

Measurable residual disease monitoring by NGS before allogeneic hematopoietic cell transplantation in AML

Felicitas Thol, Razif Gabdoulline, Alessandro Liebich et al. · Blood · 2018 · 301 citations · Full text

Medicine, Hematology, Oncology +12

Prognostic Significance of<i>ASXL1</i>Mutations in Patients With Myelodysplastic Syndromes

Felicitas Thol, Inna Friesen, Frédérik Damm et al. · Journal of Clinical Oncology · 2011 · 275 citations · Full text

Medicine, Hematology, Molecular Genetics +17

Mutant IDH1 promotes leukemogenesis in vivo and can be specifically targeted in human AML

Anuhar Chaturvedi, Michelle Cruz, Nidhi Jyotsana et al. · Blood · 2013 · 208 citations · Full text

Medicine, Genetics, Molecular Genetics +10

Mutations in the cohesin complex in acute myeloid leukemia: clinical and prognostic implications

Felicitas Thol, Robin Bollin, Marten Gehlhaar et al. · Blood · 2013 · 204 citations

Life Sciences, Genetics, Molecular Genetics +16